LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
公司代碼LNSR
公司名稱LENSAR Inc
上市日期Sep 21, 2020
CEOCurtis (Nicholas T)
員工數量140
證券類型Ordinary Share
年結日Sep 21
公司地址2800 Discovery Drive
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編32826
電話18885367271
網址https://www.lensar.com/
公司代碼LNSR
上市日期Sep 21, 2020
CEOCurtis (Nicholas T)